Cargando…

Can Mitochondria DNA Provide a Novel Biomarker for Evaluating the Risk and Prognosis of Colorectal Cancer?

Colorectal cancer (CRC) was one of the most frequent cancers worldwide. Accurate risk and prognosis evaluation could obtain better quality of life and longer survival time for the patients. Current research hotspot was focus on the gene biomarker to evaluate the risk and prognosis. Mitochondrion con...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuwen, Han, Xi, Yang, Yuefen, Pan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376434/
https://www.ncbi.nlm.nih.gov/pubmed/28408773
http://dx.doi.org/10.1155/2017/5189803
_version_ 1782519157192916992
author Shuwen, Han
Xi, Yang
Yuefen, Pan
author_facet Shuwen, Han
Xi, Yang
Yuefen, Pan
author_sort Shuwen, Han
collection PubMed
description Colorectal cancer (CRC) was one of the most frequent cancers worldwide. Accurate risk and prognosis evaluation could obtain better quality of life and longer survival time for the patients. Current research hotspot was focus on the gene biomarker to evaluate the risk and prognosis. Mitochondrion contains its own DNA and regulates self-replicating so that it can be as a candidate biomarker for evaluating the risk and prognosis of colorectal cancer. But there were already huge controversies on this issue. The review was to summarize current viewpoints of the controversial issues and described our understanding from the four aspects including mtDNA copy number, mitochondrial displacement loop, mtDNA variation, and mtDNA microsatellite instability, wishing the summary of the mtDNA in colorectal cancer could provide a meaningful reference or a valuable direction in the future studies.
format Online
Article
Text
id pubmed-5376434
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-53764342017-04-13 Can Mitochondria DNA Provide a Novel Biomarker for Evaluating the Risk and Prognosis of Colorectal Cancer? Shuwen, Han Xi, Yang Yuefen, Pan Dis Markers Review Article Colorectal cancer (CRC) was one of the most frequent cancers worldwide. Accurate risk and prognosis evaluation could obtain better quality of life and longer survival time for the patients. Current research hotspot was focus on the gene biomarker to evaluate the risk and prognosis. Mitochondrion contains its own DNA and regulates self-replicating so that it can be as a candidate biomarker for evaluating the risk and prognosis of colorectal cancer. But there were already huge controversies on this issue. The review was to summarize current viewpoints of the controversial issues and described our understanding from the four aspects including mtDNA copy number, mitochondrial displacement loop, mtDNA variation, and mtDNA microsatellite instability, wishing the summary of the mtDNA in colorectal cancer could provide a meaningful reference or a valuable direction in the future studies. Hindawi 2017 2017-03-16 /pmc/articles/PMC5376434/ /pubmed/28408773 http://dx.doi.org/10.1155/2017/5189803 Text en Copyright © 2017 Han Shuwen et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Shuwen, Han
Xi, Yang
Yuefen, Pan
Can Mitochondria DNA Provide a Novel Biomarker for Evaluating the Risk and Prognosis of Colorectal Cancer?
title Can Mitochondria DNA Provide a Novel Biomarker for Evaluating the Risk and Prognosis of Colorectal Cancer?
title_full Can Mitochondria DNA Provide a Novel Biomarker for Evaluating the Risk and Prognosis of Colorectal Cancer?
title_fullStr Can Mitochondria DNA Provide a Novel Biomarker for Evaluating the Risk and Prognosis of Colorectal Cancer?
title_full_unstemmed Can Mitochondria DNA Provide a Novel Biomarker for Evaluating the Risk and Prognosis of Colorectal Cancer?
title_short Can Mitochondria DNA Provide a Novel Biomarker for Evaluating the Risk and Prognosis of Colorectal Cancer?
title_sort can mitochondria dna provide a novel biomarker for evaluating the risk and prognosis of colorectal cancer?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376434/
https://www.ncbi.nlm.nih.gov/pubmed/28408773
http://dx.doi.org/10.1155/2017/5189803
work_keys_str_mv AT shuwenhan canmitochondriadnaprovideanovelbiomarkerforevaluatingtheriskandprognosisofcolorectalcancer
AT xiyang canmitochondriadnaprovideanovelbiomarkerforevaluatingtheriskandprognosisofcolorectalcancer
AT yuefenpan canmitochondriadnaprovideanovelbiomarkerforevaluatingtheriskandprognosisofcolorectalcancer